Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Voyager Therapeutics (VYGR) Prepaid Assets (2016 - 2025)

Voyager Therapeutics (VYGR) has disclosed Prepaid Assets for 11 consecutive years, with $4.3 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 50.59% to $4.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Dec 2025, up 50.59% year-over-year, with the annual reading at $4.3 million for FY2025, 50.59% up from the prior year.
  • Prepaid Assets hit $4.3 million in Q4 2025 for Voyager Therapeutics, down from $6.6 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $10.1 million in Q1 2021 to a low of $607000.0 in Q4 2023.
  • Historically, Prepaid Assets has averaged $5.0 million across 5 years, with a median of $4.7 million in 2022.
  • Biggest five-year swings in Prepaid Assets: plummeted 64.16% in 2022 and later surged 373.48% in 2024.
  • Year by year, Prepaid Assets stood at $1.4 million in 2021, then tumbled by 48.82% to $696000.0 in 2022, then dropped by 12.79% to $607000.0 in 2023, then soared by 373.48% to $2.9 million in 2024, then surged by 50.59% to $4.3 million in 2025.
  • Business Quant data shows Prepaid Assets for VYGR at $4.3 million in Q4 2025, $6.6 million in Q3 2025, and $9.8 million in Q2 2025.